EXEL241115C32000
- 3.93
- +0.75+23.58%
Exelixis Newsroom
Exelixis(EXEL.US) Officer Sells US$3.39 Million in Common Stock
$Exelixis(EXEL.US)$ Officer Aftab Dana sold 96,986 shares of common stock on Nov 5, 2024 at an average price of $35 for a total value of $3.39 million.Source: Announcement What is statement of
Form 144 | Exelixis(EXEL.US) Officer Proposes to Sell 3.39 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 5, $Exelixis(EXEL.US)$ Officer DANA T AFTAB intends to sell 96,986 shares of its common stock on Nov 5, with a total market value of approximately $3.39 million. DANA T
Here Is Why Growth Investors Should Buy Exelixis (EXEL) Now
Earnings Estimates Rising for Exelixis (EXEL): Will It Gain?
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Earnings Call: Exelixis Reports Solid Growth, Raises 2024 Revenue Guidance
Further Upside For Exelixis, Inc. (NASDAQ:EXEL) Shares Could Introduce Price Risks After 25% Bounce
Exelixis Price Target Raised to $36 From $33 at Piper Sandler
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
Exelixis Price Target Raised to $36.00/Share From $32.00 by Wells Fargo
Exelixis Up Over 15%, On Track for Highest Close Since September 2000 -- Data Talk
Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook
Exelixis Is Maintained at Outperform by BMO Capital
Exelixis Analyst Ratings
A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $29 to $38
S&P 500 Futures Climb In Premarket Trading; Reddit, Garmin Lead
Express News | Exelixis Inc : Stephens Raises Target Price to $29 From $23
US stocks are moving abnormally | exelixis rose about 6% before the market, Q3 performance exceeded expectations, raising revenue forecast.
Gelonghui October 30th | exelixis (EXEL.US) rose 5.78% to $30.39 before the market. The company's adjusted earnings per share for the third quarter were $0.47, higher than the expected $0.35, with sales of $539.542 million, surpassing the expected $490.02 million. The company raised its full-year net product revenue forecast for 2024. (Gelonghui)
Exelixis, Inc. (EXEL) Q3 2024 Earnings Call Transcript Summary